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INTRODUCTION
Acanthamoeba is a free-living protozoan and has been isolat-
ed from diverse environments, including air, soil, tap water, or 
swimming pools [1]. It is recognized as one of the most ubiq-
uitous protozoans [1]. Acanthamoeba is an opportunistic hu-
man pathogen and can cause a rare form of granulomatous 
encephalitis which almost always results in death or a common 
keratitis with consequences of blindness [2-4]. However, the 
pathogenesis and pathophysiology associated with Acantham­
oeba infections remain incompletely understood. Acanthamoe­
ba has been shown to demonstrate several extracellular toxins, 
particularly extracellular proteases which might contribute to-
wards its pathogenicity. Previous studies have shown the pres-
ence of phospholipases in Acanthamoeba; however, our knowl-
edge of the role of phospholipases in the virulence of Acan­
thamoeba is unclear [5-7]. Besides their role in remodelling of 
the plasma membrane of the parasite itself, based on the fact 
that phospholipases are known to cleave phospholipids, they 
may involve in the host cell plasma membrane disruptions 
leading to penetration of the host cells, and cell lysis [5-7]. This 
suggests that an understanding of the phospholipases in the 
biology and pathogenesis of Acanthamoeba may identify targets 
for therapeutic interventions.
Phospholipases are a diverse group of enzymes that hydro-
lyze ester linkage in glycerophospholipids and are involved in 
the biosynthesis and degradation of membrane lipids. Thus, 
the activities of phospholipases can result in membrane dys-
function. The 5 major known phospholipases are A1, A2, B, C, 
and D, each having the ability to cleave a specific ester bond in 
the phospholipid substrate of the target membrane [8]. For ex-
ample, PLA1 hydrolyses the fatty acyl ester bond at the sn-1 po-
sition of the glycerol moiety, while PLA2 removes the fatty acid 
at the sn-2 position of glycerol [8]. The results of both the PLA1 
and PLA2 action are free fatty acids or acyl lysophospholipid. 
The latter are further cleaved by the action of lysophospholi-
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pases. Phospholipase B has both hydrolase activities, such as 
cleaving fatty acids from phospholipids and lysophospholip-
ids as well as acyltransferase activity, for instance, the produc-
tion of phospholipids by transferring a free fatty acid to a lyso-
phospholipid [8]. Phospholipase C hydrolyses phosphodiester 
bond to yield 1,2-diacylglycerol depending on the phospho-
lipid class involved, while PLD hydrolyses the phosphodiester 
bond between the phosphate and the polar head group, pro-
ducing phosphatidic acid and choline [8-10]. All phospholi-
pases are present in multiple forms. For example, approximate-
ly 20 different PLA2 enzymes have been identified in mamma-
lian tissues and have been broadly classified into 3 families 
based on their calcium requirement for catalytic activity [8,11, 
12]. Different parts of the breakages by PLA2 and PLD are fo-
cused on this study. Victoria and Korn [6] observed that PLA 
of Acanthamoeba castellanii was located in the plasma mem-
brane [6]. It may be affected on binding of Acanthamoeba to 
target cells. The aims of the present study were to determine 
PLA2 and PLD activities in Acanthamoeba and to determine their 
role in Acanthamoeba binding to, and cytotoxicity of, human 
brain microvascular endothelial cells (HBMEC).
MATERIALS AND METHODS
Culture of Acanthamoeba
All chemicals were purchased from Sigma Laboratories (Po-
ole, Dorset, UK), unless otherwise stated. The following Acan­
thamoeba isolates of different pathogenicity were used; (1) a 
clinical isolate of A. castellanii belonging to T4 genotype, iso-
lated from a keratitis patient (ATCC 50492) (American Type 
Culture Collection, Manassas, USA), (2) a clinical isolate of A. 
castellanii belonging to T1 genotype, isolated from an encepha-
litis patient (ATCC 50494), and (3) an environmental isolate 
of Aanthamoeba astronyxis belonging to T7 genotype, isolated 
from soil (ATCC 30137). All amoebae were grown in 15 ml of 
PYG medium (proteose peptone 0.75% w/v, yeast extract 0.75% 
w/v, and glucose 1.5% w/v) at 30˚C and the media was refresh-
ed 17-20 hr prior to experiments as previously described [13]. 
This re  sulted in more than 99% amoebae in trophozoite forms, 
which were used for subsequent experiments.
Human brain microvascular endothelial cells (HBMEC)
The primary HBMEC were isolated from the human brain 
tissue and cultured as previously described [14,15]. In brief, 
HBMEC were purified by fluorescent activated cell sorting (FA-
CS) and tested for endothelial characteristics, such as the ex-
pression of endothelial markers, F-VIII, carbonic anhydrase IV, 
and the uptake of acetylated low density lipoprotein (AcLDL), 
resulting in more than 99% pure cultures. HBMEC were rou-
tinely grown on rat tail collagen-coated dishes in RPMI-1640 
containing 10% heat inactivated fetal bovine serum, 10% Nu 
serum, 2 mM glutamine, 1 mM sodium pyruvate, penicillin 
(100 U/ml), streptomycin (100 U/ml), non-essential amino 
acids, and vitamins [14,15].
Adhesion assays
Adhesion assays were performed as previously described [4]. 
Briefly, HBMEC were grown to confluency in 24-well plates. 
Acanthamoeba isolates (2×10
5 amoebae/0.5 ml/well) were in-
cubated with cell monolayers in RPMI-1640 containing 2 mM 
glutamine, 1 mM sodium pyruvate, and non-essential amino 
acids. The plates were incubated at 37˚C in a 5% CO2 incuba-
tor. After 60 min incubations, the numbers of unbound amoe-
bae in the supernatants were determined by hemocytometer 
counting. The percentage of bound amoebae was calculated as 
follows: Number of unbound amoebae/Total number of amo-
ebae×100=% unbound amoebae. The numbers of bound 
amoebae were deduced as follows: 100–% unbound amoe-
bae=% bound amoebae.
To determine the role of PLA2 and PLD in Acanthamoeba ad-
hesion to the HBMEC, assays were performed in the presence 
of phospholipase inhibitors. Briefly, amoebae were pre-incu-
bated with the phospholipase inhibitors for 45 min at room 
temperature. Following this incubation, amoebae plus inhibi-
tors were transferred to HBMEC monolayers for adhesion as-
says as described above. The following phospholipase inhibi-
tors were used: cytidine 5´-diphosphocholine, i.e., PLA2 inhibi-
tor; and compound 48/80, i.e., PLC/PLD inhibitor. 
Cytotoxicity assay
To determine the role of phospholipases in Acanthamoeba-
mediated HBMEC death, cytotoxicity assays were performed 
as previously described [13]. In brief, amoebae in the presence 
or absence of phospholipase inhibitors were added to HBMEC 
monolayers as described for adhesion assays. The plates were 
observed periodically for monolayer disruptions under a phase-
contrast microscope for up to 24 hr. Following this incubation, 
the supernatants were collected and examined for host cell cy-
totoxicity by measuring lactate dehydrogenase (LDH) release 
(cytotoxicity detection kit; Roche Applied Science, Lewes, East   Matin and Jung: Phospholipase activities in Acanthamoeba isolates   3
Sussex, UK). In brief, the supernatants of co-cultures of Acan­
thamoeba and the host cells were assessed for the presence of 
LDH, the release of which is considered as an estimate of cell 
death. The percentage LDH release was calculated as follows: 
(LDH activity in experimental sample as measured by optical 
density at 492 nm–LDH activity in control samples]/(total LDH 
activity release–LDH activity in control samples)×100=% cy-
totoxicity. Control samples were obtained from host cells or 
Acanthamoeba incubated alone. Total LDH activity release was 
determined by total host cell lysis with 1% Triton X-100 for 30 
min at 37˚C.
Phospholipase A2 assay
To determine the activity of phospholipases, the characteris-
tics of L-α-glycerophosphate oxidase for PLA2 and choline oxi-
dase for PLD were used. Acanthamoeba PLA2 activities were de-
termined using parasite lysates and their conditioned medium 
in a spectrophotometric-based assay. To prepare lysates, amoe-
bae were lysed using freeze-thaw method as previously descri-
bed [16]. In brief, various numbers of amoebae were resuspen-
ded in 100 µl of PBS, followed by freeze-thaw for 3 times. To 
prepare the conditioned medium, Acanthamoeba were incubat-
ed in RPMI-1640 for 24 hr. Next day, the cell-free conditioned 
medium was collected by centrifugation and used for PLA2 as-
says. A 100 µl of amoebae lysate or conditioned medium was 
incubated with 900 µl of PLA2 substrate solution (0.2 M D, L-α-
glycerophosphate, 0.1% 4-aminoantipyrine, 0.1% phenol, and 
0.025% peroxidase dissolved in 0.125 M Tris-HCl buffer, pH 
8.0). The reaction mixtures were incubated for 2 hr. After this 
incubation, the mixtures were centrifuged at 900 g for 5 min 
and supernatants were collected and their optical density de-
termined at 500 nm. The PLA2 activity was calculated as fol-
lows: (OD test–OD blank)×Vt×df/13.3×0.5×t×1.0×Vs= 
enzymatic activity (units per ml). Here, Vt is total volume; Vs 
is sample volume; 13.3 is the millimolar extinction coefficient 
of quinoneimine dye under the assay condition; 0.5 is the fac-
tor based on the fact that 1 mole of H2O2 produces half a mole 
of quinoneimine dye; t is reaction time; 1.0 is light path (cm); 
and df is the dilution factor. To determine the optimal activity, 
PLA2 assays were performed using various numbers of amoe-
bae at different pH and temperatures.
Phospholipase D assay
Acanthamoeba PLD activities were determined using parasite 
lysates and their conditioned medium in a spectrophotomet-
ric-based assay. The lysates and conditioned medium were pre-
pared as described above. A 100 µl of amoebae lysate or condi-
tioned medium was incubated with 900 µl of PLD substrate 
solution (2.1% choline chloride, 1% 4-aminoantipyrine, 1% 
phenol, and 5 mg peroxidase in 0.1 M Tris-HCl buffer, pH 
8.0). The reaction mixtures were incubated for 2 hr. After this 
incubation, the mixtures were centrifuged at 900 g for 5 min, 
and supernatants were collected and their optical density de-
termined at 500 nm. The PLD activity was calculated as fol-
lows: (OD test–OD blank)/min×Vt×df/12.0×0.5×1.0×Vs=
enzymatic activity (units per ml). Here, Vt is total volume; Vs 
is sample volume; 12.0 is the millimolar extinction coefficient 
of quinoneimine dye under the assay condition; 0.5 is the fac-
tor based on the fact that 1 mole of H2O2 produces half a mole 
of quinoneimine dye; t is reaction time; 1.0 is light path (cm); 
and df is the dilution factor.
RESULTS
Acanthamoeba exhibit PLA2 activities
Both clinical and environmental isolates of Acanthamoeba 
exhibited PLA2 activities (Fig. 1). As expected, optimal PLA2 ac-
tivities were observed with increasing numbers of Acanthamoe­
ba. Interestingly, the environmental isolate belonging to T7 
genotype exhibited the maximum PLA2 activities, followed by 
the encephalitis isolate belonging to the T1 genotype, while 
the keratitis isolate belonging to the T4 genotype exhibited the 
least PLA2 activities (Fig. 1). Of interest, Acanthamoeba condi-
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Fig. 1. Acanthamoeba exhibiting PLA2 activities. Both the en­
cephalitis (A) and the environmental (C) isolates exhibited opti­
mal, while the keratitis isolate (B) exhibited the least PLA2 activi­
ties. Results are representative of 3 independent experiments 
performed in triplicate. Bars represent standard errors.4   Korean J Parasitol. Vol. 49, No. 1: 1-8, March 2011
tioned medium did not exhibit PLA2 activities in the assay con-
ditions tested in the present study, suggesting that PLA2 are cell-
associated and/or not released (data not shown).
PLD activities
The results revealed that both clinical and environmental 
isolates of Acanthamoeba exhibit PLD activities (Fig. 2). Again, 
the encephalitis isolate (T1) and environmental isolate (T7) 
exhibited the highest levels of PLD activities compared with 
the keratitis isolate (T4) (Fig. 2). It was interesting to note that 
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Fig. 2. Clinical and environmental Acanthamoeba isolates ex­
hibiting PLD activities. As for PLA2, both the encephalitis (A) and 
the environmental (C) isolates exhibited optimal, while the kerati­
tis isolate (B) exhibited the least PLD activities. Results are rep­
resentative of 3 independent experiments performed in triplicate. 
Bars represent standard errors.
PLD activities in Acanthamoeba were significantly greater com-
pared with Acanthamoeba PLA2 activities (Figs. 1, 2). As for PLA2, 
the Acanthamoeba conditioned medium did not exhibit PLD 
activity in the assay conditions tested in the present study, in-
dicating that PLD activities are cell-associated and/or not re-
leased (data not shown).
 
Optimal phospholipase activities at 37˚C
To determine the optimum phospholipase activities, assays 
were performed at various temperatures from 4˚C to 65˚C. The 
optimal phospholipase activities were observed at 37˚C sug-
gesting their physiological relevance (Fig. 3). Similar findings 
were observed both with PLA2 and PLD activities. Activities 
were also observed at 65˚C, suggesting that Acanthamoeba PLA2 
and PLD activities are stable at higher temperatures (Fig. 3).
Optimal phospholipase activities at neutral pH
Next to determine the pH for optimal phospholipase activi-
ties, assays were performed at various pH. Our findings reveal-
ed that Acanthamoeba exhibit optimal PLA2 and PLD activities 
at neutral pH indicating their physiological relevance (Fig. 4). 
Both clinical and environmental isolates exhibited optimal 
phospholipase activities at pH 7.5.
Phospholipase inhibitors blocked the environmental 
isolate binding to HBMEC, but not clinical isolates 
To determine whether phospholipases play a role in Acan­
Fig. 3. Acanthamoeba exhibiting optimal phospholipase activities at 37˚C. To determine optimal temperatures of Acanthamoeba phos­
pholipases, assays were performed at various temperatures using Acanthamoeba lysates (5×10
6 amoebae). Note that all Acantham-
oeba isolates tested exhibit optimal PLA2 (A) and PLD (B) activities at 37˚C indicating their physiological relevance. Results are repre­
sentative of 3 independent experiments performed in triplicate. Bars represent standard errors.
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thamoeba binding to the host cells, adhesion assays were per-
formed using the PLA2 inhibitor, i.e., cytidine 5´-diphospho-
choline, and the PLC/PLD inhibitor, i.e., compound 48/80. Our 
findings revealed that neither phospholipase inhibitor had any 
significant effects on the adhesion of clinical isolates of Acan­
thamoeba to HBMEC (Fig. 5). In contrast, adhesion of the envi-
ronmental isolate of Acanthamoeba was completely abolished 
in the presence of phospholipase inhibitors (Fig. 5). 
Phopholipase A2 inhibitor had no effect on Acanthamoeba- 
mediated HBMEC cytotoxicity
To determine the role of PLA2 in Acanthamoeba-mediated 
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Fig. 4. Acanthamoeba exhibiting optimal phospholipase activities at neutral pH. To determine optimal pH of Acanthamoeba phos­
pholipases, assays were performed at various pH using Acanthamoeba lysates (5×10
6 amoebae). Note that all Acanthamoeba iso­
lates tested exhibit optimal PLA2 (A) and PLD (B) activities at neutral pH indicating their physiological relevance. Results are represen­
tative of 3 independent experiments performed in triplicate. Bars represent standard errors.
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Fig. 5. Phospholipase inhibitors blocking the environmental iso­
late­mediated binding to HBMEC but not the clinical isolates­
mediated binding. The results revealed that both phospholipase 
inhibitors restricted environmental isolate (C)­mediated binding to 
HBMEC. How  ever, neither inhibitors had any effects on the clini­
cal isolates (A, T1; B, T4). Results are representative of 3 inde­
pendent experiments performed in duplicates. Bars represent 
standard errors.
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HBMEC death, cytotoxicity assays were performed in the pres-
ence of cytidine 5´-diphosphocholine, a PLA2-specific inhibi-
tor. The results revealed that cytidine 5´-diphosphocholine had 
no significant effect on parasite-mediated HBMEC cytotoxicity 
in all Acanthamoeba isolates tested (Fig. 6).
Phopholipase C/D inhibitor inhibited HBMEC cytotoxicities 
mediated by the encephalitis isolate but not by the 
keratitis isolate
To determine whether PLC/PLD plays a role in Acanthamoe­
ba-mediated HBMEC death, cytotoxicity assays were performed 
in the presence of compound 48/80. Interestingly, compound 
48/80 partially blocked the encephalitis isolate-mediated HB-
MEC cytotoxicity, i.e., 49% cell death in the presence of the in-
hibitor compared with 73% in the absence of the inhibitor 
(Fig. 6). However, it had no effect on the keratitis isolate-medi-
ated HBMEC cytotoxicity (Fig. 6). In contrast, the effects of 
phospholipase inhibitors on the environmental isolate-medi-
ated HBMEC cytotoxicity remained unclear. This was due to 
the fact that the environmental isolate exhibited minimal HB-
MEC cytotoxicity even in the absence of inhibitors.
DISCUSSION
Infections due to Acanthamoeba have increased over the years. 
This is most likely due to the increasing numbers of contact 
lens wearers, increasing populations of immunocompromised 
patients, and global warming. This has led to a remarkable in-
terest in the field of Acanthamoeba pathogenesis and to design 
strategies to control and prevent Acanthamoeba infections. In 
particular, over the last 2 decades, research in Acanthamoeba 
virulence factors has gained significant attention to identify 
novel approaches for therapeutic interventions. Acanthamoeba 
pathogenesis is attributed to their ability to bind to the host 
cells, induce host cell apoptosis, secrete proteases, exhibit ecto-
ATPase activities, and switch phenotypes. The present study 
was undertaken to determine the roles of phospholipases (i.e., 
PLA2 and PLD) in Acanthamoeba and Acanthamoeba-mediated 
binding to, and cytotoxicity of HBMEC in vitro. Our findings 
revealed that Acanthamoeba show PLA2 and PLD activities. This 
is consistent with previous studies that showed the presence of 
phospholipase activities in Acanthamoeba [5-7].
It was interesting to note that the environmental isolate (be-
longing to the T7 genotype) exhibited higher phospholipase 
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Fig. 6. Compound 48/80 partially inhibiting encephalitis isolate­
mediated HBMEC cytotoxicity. The results revealed that cytidine 
5´­diphosphocholine had no significant effect on Acanthamoe-
ba­mediated HBMEC cytotoxicity. Similarly, compound 48/80 
had no effect on Acanthamoeba keratitis isolate (B) but partially 
inhibited encephalitis isolate (A)­mediated HBMEC cytotoxicity. 
C is a environmental isolate of T7. Results are representative of 
3 independent experiments performed in duplicates. Bars rep­
resent standard errors.
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activities as compared to the keratitis isolate (belonging to the 
T4 genotype). In contrast, the environmental isolate exhibited 
minimal binding to or cytotoxicity of HBMEC. This is not a 
surprising finding. Being a free-living amoeba, the primary func-
tions of phospholipases in Acanthamoeba may be predominant-
ly in the phospholipids turnover for membrane maintenance 
and remodelling. The fact that environmental isolate is signifi-
cantly larger in size as compared to the keratitis isolate, thus 
larger plasma membranes, may explain its optimal PLA2 and 
PLD activities, and thus rationalize these findings. In support, 
the size of keratitis isolate tested here is approximately 7 µm. 
The size of the encephalitis isolate is approximately 10 µm and 
the environmental isolate being the largest, approximately 17 
µm. Another explanation may be that the environmental iso-
late exhibited distinct types or isoforms of phospholipases com-
pared with the clinical isolates. For example, Sissons et al. [17] 
have shown that both clinical and environmental isolates of 
Acanthamoeba exhibit ecto-ATPase activities, however, clinical 
isolates exhibit distinct ecto-ATPases. This may be the case for 
phospholipases, which are normally required for routine cel-
lular functions but pathogenic isolates may possess distinct 
phospholipases. The fact that compound 48/80 had no effect 
on keratitis isolate-mediated host cell death but partially in-
hibited encephalitis isolate-mediated HBMEC cytotoxicity fur-
ther suggests possible differences in phospholipases in Acan­
thamoeba belonging to different genotypes. Future studies are 
in progress to determine the molecular basis of these differ-
ences.
Of interest was the observation that compound 48/80, only 
partially inhibited encephalitis isolate-mediated HBMEC cyto-
toxicity. It is noteworthy that Acanthamoeba pathogenesis is a 
multifactorial process involving adherence, phagocytosis, apop-
tosis, proteases, ecto-ATPases, and the inhibition of a single pu-
tative factor may not be sufficient to block their ability to pro-
duce host cell cytotoxicity. In support, previous studies have 
shown that inhibition of Acanthamoeba binding to host cells is 
not adequate to block host cell cytotoxicity [18]. At present, the 
inability of compound 48/80 to block keratitis isolate-mediat-
ed host cell death is unclear. To this end, the source of amoeba 
isolates, i.e., keratitis and encephalitis patients may be indica-
tive of these differences. This possibly means that phospholi-
pases from the encephalitis isolate may play a role in the patho-
genesis of AGE. However, it is a subject which needs additional 
research and study.
The finding that phospholipase inhibitors did not clearly 
block Acanthamoeba-mediated HBMEC cytotoxicity does not 
rule out their involvement in Acanthamoeba pathogenesis. It is 
possible that cytotoxicity is a delayed event and that phospho-
lipases are involved in the early events. Recent studies have 
shown that phospholipases may be involved in interference 
with the intracellular signalling pathways. For example, phos-
pholipases generate lipids and lipid-derived products that act 
as mediators and second messengers, which may act as the mo-
dulators of signal transduction pathway [19,20]. Oishi et al. 
[21] showed that lysophospholipids, by-end products of PLA2 
and PLB, induce activation of protein kinase C, which has di-
verse functions in host cell signalling pathways [21]. Phospho-
lipase C of Clostridium perfringens induces expression of IL-8 
synthesis in endothelial cells [22,23]. Phospholipase A facili-
tate host cell penetration of Toxoplasma gondii [24] and Entamo­
eba histolytica [25], while PLD has been shown to be an impor-
tant virulence determinant of Corynebacterium pseudotuberculosis 
in the persistence and spread of bacteria within the host [26].
Overall, these studies suggest that Acanthamoeba phospholi-
pases may play a role in causing host cell damage or affect oth-
er cellular functions, such as inducing inflammatory responses 
and thus facilitating the virulence of Acanthamoeba. The fact 
that phospholipases cleave phospholipids suggests their possi-
ble role in membrane disruptions and penetration into host 
cells. Future studies are needed to identify and characterize 
Acanthamoeba phospholipases, which should help determine 
their potential role for therapeutic interventions and in differ-
entiation of Acanthamoeba isolates belonging to different geno-
types. Some previous studies have shown that phospholipase 
C from C. perfringens induced protection against C. perfringens-
mediated gas gangrene [27]. In addition, targeting phospholi-
pases using synthetic compounds are shown to have the po-
tential to prevent Candida infections [28].
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